期刊文献+

婴幼儿支原体肺炎炎性相关指标的变化和临床意义 被引量:3

原文传递
导出
摘要 目的:支原体肺炎(MPP)是指由肺炎支原体引起的肺部急性炎症,多见于儿童和青少年,但近年来婴幼儿患病率增加。本文以婴幼儿MPP病例资料为研究对象,总结婴幼儿MPP实验室特征,为临床诊断小儿MPP提供实验室依据。方法研究2012年3月~2013年1月在我院呼吸内科住院的患儿25名,分析WBC、CRP、ESR等炎性指标的变化情况,总结婴幼儿MPP实验室特征。结果 MPP患儿于起病后10~15天后进行MP-IgM检查,会提高MP-IgM阳性检出率;多数患儿WBC计数属于正常范围,部分轻度升高;CRP可以作为提示MP早期感染的指标。结论当临床怀疑婴幼儿支原体肺炎时,应当及时检测血常规和CRP等,并且在起病后10天左右进行MP-IgM检查,有助于临床诊断。
作者 宋敏
出处 《首都医药》 2014年第20期48-49,共2页 Capital Medicine
  • 相关文献

参考文献6

  • 1潘巧玉,陶双.婴幼儿重症支原体肺炎35例临床分析[J].中国临床医生杂志,2011,39(9):45-46. 被引量:2
  • 2胡亚美,江载芳.实用儿科学(第7版)[M].北京:人民卫生出版社,2002,1204-1205.
  • 3Ouchi K. The role of atypical pathogen:Mycoplasma pneumoniae and Chlamydia pneumoniae in the acute respiratory infection in childhood[J].Jpn J Antibiot, 2000,53 Suppl B:13-21.
  • 4Principi N, Esposito S. Mycoplasma pneumoniae and Chlamydia pneumoniae cause lower respiratory tract disease in paediatric patients[J].Curr Opin Infect Dis, 2002,15 (3): 295- 300.
  • 5Smith-Norowitz Th, Silverberg JI, Kusonruksa M, et al. Asthmatic Children Have Increased Specific Anti-Mycoplasma pneumoniae IgM but not IgG or IgE-Values Independent of History of Respiratory Tract Infection[J].Pediatr Infect Dis J, 2013, 32 (6): 599- 603.
  • 6Hu CF, Wang CC, Chen SJ,et al. Prognostic values of a combination of intervals between respiratory illness and onset of neurological symptoms and elevated serum IgM titers in Mycoplasma pneumoniae encephalopathy[J].J Microbiol Immunol Infect, 2013, Aug, 19, pii: S1684-1182 (13) 00115-1.

二级参考文献7

共引文献1

同被引文献44

  • 1Chironna M, Sallustio A, Esposito S, et al. Emergence of mac- rolide-resistaut strains during an outbreak of Mycoplasma pneu- moniae infections in children [J]. J Antimicrob Chemother, 2011,66(4) : 734-737.
  • 2Yoo SJ, Kim HB, Choi SH, et al. Differences in the frequency of 23S rRNA gene mutations in Mycoplasma pneumoniae be- tween children and adults with community-acquired pneumo- nia: clinical impact of mutations conferring macrolide resis- tance [J]. Antimicrob Agents Chemother, 2012, 56 (12) : 6393-6396.
  • 3Kawai Y, Miyashita N, Kubo M, et al. Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pe- diatric patients[J]. Antimicrobial Agents and Chemotherapy, 2013, 57(8): 4046-4049.
  • 4Hong KB, Choi EH, Lee HJ, et al. Macrolide resistance of My- coplasma pneumoniae, South Korea, 2000-2011 [J]. Emerging Infect Dis, 2013,19(8) : 1281-1284.
  • 5Bezerra PGM, Britto MCA, Correia JB, et al. Viral and atypi- cal bacterial detection in acute respiratory infection in children under five years[J]. PloS One, 2011,6(4) : e18928.
  • 6Youn YS, Lee KY, Hwang JY, et al. Difference of clinical fea- tures in childhood Mycoplasma pneumoniae pneumonia [J]. BMC Pediatrics, 2010, 10( 1 ) : 48.
  • 7Principi N, Esposito S. Macrolide-resistant Mycoplasma pneu- moniae: its role in respiratory infection [J]. J Antimicrob Che- mother, 2013,68 (3) : 506-511.
  • 8Jiang W, Yan Y, Ji W, et al. Clinical significance of different bacterial load of Mycoplasma pneumoniae in patients with Myco- plasma pneumoniae pneumonia [J]. Brazilian J Infect Dis, 2014, 18(2): 124-128.
  • 9Kannan TR, Hardy RD, Coalson J J, et al. Fatal outcomes in family transmission of Mycoplasma pneumoniae [ J ]. Clin Infect Dis, 2012, 54(2): 225-231.
  • 10Kumar S, Maria A, Saigal SR, et al. Mycoplasma pneumoniae as a cause of non-resolving pneumonia in a neonate[J]. J Med Microbiol, 2010,59 (6) : 731-732.

引证文献3

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部